Global Patent Index - EP 0222834 A4

EP 0222834 A4 19891004 - TREATMENT OF NON-ULCER DYSPEPSIA WITH BISMUTH SALTS.

Title (en)

TREATMENT OF NON-ULCER DYSPEPSIA WITH BISMUTH SALTS.

Title (de)

BEHANDLUNG VON NICHTULCERATIVER DYSPEPSIA MIT WISMUTSALZEN.

Title (fr)

TRAITEMENT DE LA DYSPEPSIE NON ULCEREUSE AVEC DES SELS DE BISMUTH.

Publication

EP 0222834 A4 19891004 (EN)

Application

EP 86903120 A 19860418

Priority

AU PH019885 A 19850418

Abstract (en)

[origin: WO8605981A1] Treatment of non-ulcer dyspepsia associated with Campylobacter pyloridis infection by the administration of bismuth salts. The administration of bismuth salts in association with antibiotics has been found to be particularly efficacious. A pharmaceutical composition for use in the performance of the present invention is also disclosed.

IPC 1-7

A61K 31/29; A61K 31/43

IPC 8 full level

C07F 9/94 (2006.01); A61K 31/29 (2006.01); A61K 31/43 (2006.01); A61K 31/60 (2006.01); A61P 1/00 (2006.01); A61P 31/04 (2006.01)

CPC (source: EP)

A61K 31/29 (2013.01); A61K 31/43 (2013.01); A61P 1/00 (2017.12); A61P 31/04 (2017.12)

C-Set (source: EP)

  1. A61K 31/43 + A61K 31/29
  2. A61K 31/43 + A61K 2300/00

Citation (search report)

  • THE MEDICAL JOURNAL OF AUSTRALIA, vol. 142, 15th April 1985, pages 439-444; B.J. MARSHALL et al.: "Pyloric campylobacter infection and gastroduodenal disease"
  • CAMPYLOBACTER III, PROCEEDINGS OF THE THIRD INTERNATIONAL WORKSHOP ON CAMPYLOBACTER INFECTION, Ottawa, 7th-10th July 1985, page 161, abstract no. 097, Public Health Laboratory Service, London, GB; D.M. JONES et al.: "The effects of various anti-ulcer regimens and antibiotics on the presence of Campylobacter pyloridis and its antibody"
  • CAMPYLOBACTER III, PROCEEDINGS OF THE THIRD INTERNATIONAL WORKSHOP ON CAMPYLOBACTER INFECTION, Ottawa, 7th-10th July 1985, page 163, abstract no. 099, Public Health Laboratory Service, London, GB; C.A.M. McNULTY et al.: "A trial to compare treatment with pepto-bismol (bismuth subsalicylate), placebo and erythromycin for the eradication of campylobacter pyloridis in patients with gastritis"
  • CAMPYLOBACTER III, PROCEEDINGS OF THE THIRD INTERNATIONAL WORKSHOP ON CAMPYLOBACTER INFECTION, Ottawa, 7th-10th July 1985, pages 165,166, abstract no. 100, Public Health Laboratory Service, London, GB; B.J. MARSHALL et al.: "The antibacterial action of bismuth: early results of antibacterial regimens in the treatment of duodenal ulcer"
  • CAMPYLOBACTER III, PROCEEDINGS OF THE THIRD INTERNATIONAL WORKSHOP ON CAMPYLOBACTER INFECTION, Ottawa, 7th-10th July 1985, page 162, abstract no. 098, Public Health Laboratory Service, London, GB; M.L. LANGENBERG et al.: "The pathogenic role of campylobacter pyloridis studied by attempts to eliminate these organisms"
  • GASTROENTEROLOGY, vol. 88, no. 5, 1985, page 1462; J.R. LAMBERT et al.: "Campylobacter like organisms (CLO) - in vivo and in vitro susceptibility to antimicrobial and antiulcer therapy"
  • ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 28, no. 6, December 1985, pages 837-838, American Society for Microbiology; C.A.M. McNULTY et al.: "Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents"
  • IMMUNIT[T UND INFEKTION, vol. 14, no. 2, April 1986, pages 58-62; G. KASPER et al.: "Klinische Bedeutung, Epidemiologie und Laboratoriumsdiagnostik von Campylobacter pyloridis"
  • J. CLIN. PATHOL., vol. 39, 1986, pages 353-365; C.S. GOODWIN et al.: "Campylobacter pyloridis, gastritis, and peptic ulceration"
  • THE JOURNAL OF INFECTIOUS DISEASES, vol. 153, no. 4, April 1986, pages 650-657; B.J. MARSHALL: "Campylobacter pyloridis and gastritis"
  • THE LANCET, 15th August 1987, page 398; B.J. RATHBONE et al.: "Campylobacter pylori and peptic ulcer"
  • ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 23, no. 5, May 1983, pages 796-797, American Society for Micrbiology; J. MICHEL et al.: "Susceptibility of clinical isolates of campylobacter jejuni to sixteen antimicrobial agents"
  • ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 23, no. 5, May 1983, pages 796-797, American Society for Micrbiology; J. MICHEL et al.: "Susceptibility of clinical isolates of campylobacter jejuni to sixteen antimicrobial agents"
  • See references of WO 8605981A1

Designated contracting state (EPC)

AT BE CH DE FR GB IT LI LU NL SE

DOCDB simple family (publication)

WO 8605981 A1 19861023; AU 5902686 A 19861105; AU 590578 B2 19891109; EP 0222834 A1 19870527; EP 0222834 A4 19891004; JP S62502967 A 19871126; SG 72632 A1 20000523

DOCDB simple family (application)

AU 8600106 W 19860418; AU 5902686 A 19860418; EP 86903120 A 19860418; JP 50299986 A 19860418; SG 1996004300 A 19860418